Transatlantique Private Wealth’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.21M Buy
25,892
+760
+3% +$32.9K 0.38% 77
2025
Q3
$1.05M Buy
25,132
+693
+3% +$30.5K 0.34% 84
2025
Q2
$1.08M Buy
24,439
+1,009
+4% +$45.7K 0.4% 71
2025
Q1
$1.18M Buy
23,430
+475
+2% +$23.6K 0.47% 58
2024
Q4
$986K Hold
22,955
0.37% 80
2024
Q3
$900K Sell
22,955
-6,050
-21% -$219K 0.34% 87
2024
Q2
$921K Buy
29,005
+56
+0.2% +$1.81K 0.38% 72
2024
Q1
$939K Buy
28,949
+500
+2% +$17.4K 0.41% 81
2023
Q4
$969K Hold
28,449
0.45% 70
2023
Q3
$1.02M Buy
28,449
+222
+0.8% +$8.24K 0.55% 59
2023
Q2
$1.06M Buy
28,227
+769
+3% +$31K 0.55% 56
2023
Q1
$1.25M Buy
27,458
+48
+0.2% +$2.24K 0.69% 37
2022
Q4
$1.26M Buy
27,410
+4,850
+21% +$221K 0.75% 34
2022
Q3
$987K Hold
22,560
0.66% 43
2022
Q2
$956K Buy
+22,560
New +$957K 0.67% 42

Other funds holding G

Transatlantique Private Wealth's G Position: Q4 2025 in Review

Transatlantique Private Wealth increased its Genpact (G) stake by 3% in Q4 2025, buying an estimated $32.9K and bringing the position to 25,892 shares worth $1.21M. The position accounts for 0.38% of the portfolio, ranked #77.

Transatlantique Private Wealth first reported a position in G in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.26M in Q4 2022. 522 funds tracked by Wall St. Rank hold G as of Q4 2025.

  • Transatlantique Private Wealth held 25,892 shares of Genpact worth $1.21M as of Q4 2025.
  • Transatlantique Private Wealth bought 760 Genpact shares in Q4 2025, an estimated $32.9K.
  • Genpact made up 0.38% of Transatlantique Private Wealth's portfolio in Q4 2025, its #77 holding.
  • Transatlantique Private Wealth first reported a position in Genpact in Q2 2022 and has held it in 15 quarters since.
  • Transatlantique Private Wealth's Genpact position peaked at $1.26M in Q4 2022.
  • 522 funds tracked by Wall St. Rank held Genpact as of Q4 2025.

Based on Transatlantique Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.